CIK: 0002011385 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 12, 2024
Total Value ($000): $125,398 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 8,644,579 | $104,686 | 83.5% | $7.85 | +54.2% | COM | 603170101 |
| PHAT | Phathom Pharmaceuticals, Inc. | 1,122,572 | $20,296 | 16.2% | $10.53 | +32.7% | COM | 71722W107 |
| — | HilleVax, Inc. | 236,379 | $416 | 0.3% | $16.05 | — | COM | 43157M102 |